Amarin Corp Plcuk (AMRN) Cost of Revenue (2013 - 2026)

Amarin Corp Plcuk (AMRN) reported Cost of Revenue of $27.4 million for Q1 2026, up 270.57% year-over-year from $7.4 million in Q1 2025, and down 63.12% quarter-over-quarter from $74.2 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Cost of Revenue (2013 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 14 years of Cost of Revenue data on file, last reported at $27.4 million in Q1 2026.

  • Cost of Revenue for Q1 2026 came in at $27.4 million, up 270.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $126.7 million (up 133.69% YoY), and the FY2025 annual result was $92.8 million, up 131.08% from the prior year.
  • Cost of Revenue declined to $27.4 million in Q1 2026 per AMRN's latest filing, from $74.2 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $74.2 million in Q4 2025 and troughed at -$15.3 million in Q4 2023.
  • A 5-year average of $22.3 million and a median of $23.6 million in 2023 frame the typical range for Cost of Revenue.
  • The sharpest annual moves came in 2023 and 2025: Cost of Revenue plunged 143.72% in 2023, then surged 601.88% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at $35.0 million in 2022, then slumped by 143.72% to -$15.3 million in 2023, then surged by 169.05% to $10.6 million in 2024, then surged by 601.88% to $74.2 million in 2025, then tumbled by 63.12% to $27.4 million in 2026.
  • Business Quant data shows AMRN's Cost of Revenue at $27.4 million in Q1 2026, $74.2 million in Q4 2025, and $2.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 2.53 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 3.58 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 8.11 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 4.22 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 4.20 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 2.74 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 1.45 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 3.55 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 3.42 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn 27.36 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 27.36 Mn
Mar 31, 2026 27.36 Mn
Dec 31, 2025 74.20 Mn
Dec 31, 2025 74.20 Mn
Sep 30, 2025 2.72 Mn
Sep 30, 2025 2.72 Mn
Jun 30, 2025 22.38 Mn
Jun 30, 2025 22.38 Mn
Mar 31, 2025 7.38 Mn
Mar 31, 2025 7.38 Mn
Dec 31, 2024 10.57 Mn
Dec 31, 2024 10.57 Mn
Sep 30, 2024 26.02 Mn
Sep 30, 2024 26.02 Mn
Jun 30, 2024 10.22 Mn
Jun 30, 2024 10.22 Mn
Mar 31, 2024 24.62 Mn
Mar 31, 2024 24.62 Mn
Dec 31, 2023 -15.31 Mn
Dec 31, 2023 -15.31 Mn